The MedTech Europe blog

Archives for

According to EDMA’s 2012 European In Vitro Diagnostics (IVD) Market Statistics Report, the in vitro diagnostics market in Europe has decreased 2.2% in 2012. These results had been predicted in the previous EDMA report released for 2011, given austerity measures to cut costs in health expenditure. However, a decline in revenue for IVDs might have… » read more

Posted by MedTech Europe

Caveat Emptor, or ‘Buyer Beware’, is a commercial rule favouring the seller, now largely extinct due to modern consumer legislation. But the European Parliament’s ENVI Committee, in its amendment on the reprocessing of single-use medical devices, has unwittingly slipped something similar back in again. Given the complex and highly technical nature of the Medical Devices… » read more

Posted by MedTech Europe

Europe’s medical device industry has always agreed that Europe’s regulatory system for devices needs to be improved and has put forward various proposals to achieve this. In the wake of a case of fraud like the PIP breast implant incident, it is clear that we need a safer system that makes sure Europe’s patients continue… » read more

Posted by MedTech Europe

The rapid ageing of the European population has urged the need for prevention and proper treatment of age-related diseases. Amongst these priorities and priority diseases, Cataract is today the major cause of vision impairment of senior citizens worldwide, responsible of 48 % of blindness around the globe. Cataract is the clouding of the lens of… » read more

Posted by MedTech Europe